Resveratrol targets transforming growth factor-Β2 signaling to block UV-induced tumor progression

Journal of Investigative Dermatology

Volumn 131, Issue 1, 2011, Pages 195-202

  Kim, Kwang Ho ^a,b   Back, Jung Ho ^a   Zhu, Yucui ^a   Arbesman, Josh ^a   Athar, Mohammad ^c   Kopelovich, Levy ^d   Kim, Arianna L ^a   Bickers, David R ^a  

^a NewYork Presbyterian Hospital   (United States)

^b Hallym University College of Medicine   (South Korea)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CADHERIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RESVERATROL; SMAD3 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER INVASION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; MALE; MOUSE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKIN TUMOR; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; ULTRAVIOLET RADIATION;

EID: 78650302198     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2010.250     Document Type: Article

References (40)

1. Ahmad N, Adhami VM, Afaq F et al. (2001) Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7:1466-73
2. Alt-Holland A, Shamis Y, Riley KN et al. (2008) E-cadherin suppression directs cytoskeletal rearrangement and intraepithelial tumor cell migration in 3D human skin equivalents. J Invest Dermatol 128: 2498-507
3. Athar M, Back JH, Tang X et al. (2007) Resveratrol: a review of preclinical studies for human cancer prevention. Toxicol Appl Pharmacol 224:274-83
4. Aziz MH, Reagan-Shaw S, Wu J et al. (2005) Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J 19:1193-5
5. Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5:493-506
6. Benjamin CL, Ullrich SE, Kripke ML et al. (2008) p53 tumor suppressor gene: a critical molecular target for UV induction and prevention of skin cancer. Photochem Photobiol 84:55-62
7. Caravatta L, Sancilio S, di Giacomo V et al. (2008) PI3-K/Akt-dependent activation of cAMP-response element-binding (CREB) protein in Jurkat T leukemia cells treated with TRAIL. J Cell Physiol 214:192-200
8. Choi J, Park SY, Joo CK (2007) Transforming growth factor-beta1 represses E-cadherin production via slug expression in lens epithelial cells. Invest Ophthalmol Vis Sci 48:2708-18
9. Chrivia JC, Kwok RP, Lamb N et al. (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-9
10. Cui W, Fowlis DJ, Bryson S et al. (1996) TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86:531-42
11. Davies M, Robinson M, Smith E et al. (2005) Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways. J Cell Biochem 95:918-31
12. Deak M, Clifton AD, Lucocq LM et al. (1998) Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J 17:4426-41
13. Derynck R, Zhang YE (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425:577-84
14. Dong R, Wang Q, He XL et al. (2007) Role of nuclear factor kappa B and reactive oxygen species in the tumor necrosis factor-alpha-induced epithelial-mesenchymal transition of MCF-7 cells. Braz J Med Biol Res 40:1071-8
15. Du K, Montminy M (1998) CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273:32377-9
16. Garcia GE, Nicole A, Bhaskaran S et al. (2006) Akt-and CREB-mediated prostate cancer cell proliferation inhibition by Nexrutine, a Phelloden-dron amurense extract. Neoplasia 8:523-33
17. Gold LI, Jussila T, Fusenig NE et al. (2000) TGF-beta isoforms are differentially expressed in increasing malignant grades of HaCaT keratinocytes, suggesting separate roles in skin carcinogenesis. J Pathol 190:579-88
18. Han G, Lu SL, Li AG et al. (2005) Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J Clin Invest 115:1714-23
19. Hau P, Jachimczak P, Schlingensiepen R et al. (2007) Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides 17:201-12
20. Hoot KE, Lighthall J, Han G et al. (2008) Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer formation and progression. J Clin Invest 118:2722-32
21. Kim AL, Athar M, Bickers DR et al. (2002) Ultraviolet-B-induced G1 arrest is mediated by downregulation of cyclin-dependent kinase 4 in transformed keratinocytes lacking functional p53. J Invest Dermatol 118:818-24
22. Kim AL, Zhu Y, Zhu H et al. (2006) Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways. Exp Dermatol 15:538-46
23. Kingsley-Kallesen ML, Kelly D, Rizzino A (1999) Transcriptional regulation of the transforming growth factor-beta2 promoter by cAMP-responsive element-binding protein (CREB) and activating transcription factor-1 (ATF-1) is modulated by protein kinases and the coactivators p300 and CREB-binding protein. J Biol Chem 274:34020-8
24. Kumar AP, Garcia GE, Ghosh R et al. (2003) 4-Hydroxy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway: potential for prostate cancer management. Neoplasia 5:255-66
25. 0-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem Res Toxicol 5:227-31
26. Leivonen SK, Hakkinen L, Liu D et al. (2005) Smad3 and extracellular signal-regulated kinase 1/2 coordinately mediate transforming growth factor-beta-induced expression of connective tissue growth factor in human fibroblasts. J Invest Dermatol 124:1162-9
27. Lester RD, Jo M, Montel V et al. (2007) uPAR induces epithelial- mesenchymal transition in hypoxic breast cancer cells. J Cell Biol 178:425-36
28. Rahimi RA, Leof EB (2007) TGF-beta signaling: a tale of two responses. J Cell Biochem 102:593-608
29. Serrero G, Lu R (2001) Effect of resveratrol on the expression of autocrine growth modulators in human breast cancer cells. Antioxid Redox Signal 3:969-79
30. Shaywitz AJ, Greenberg ME (1999) CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68:821-61
31. Suenaga F, Hatsushika K, Takano S et al. (2008) A possible link between resveratrol and TGF-beta: resveratrol induction of TGF-beta expression and signaling. FEBS Lett 582:586-90
32. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-6
33. Thiery JP, Chopin D (1999) Epithelial cell plasticity in development and tumor progression. Cancer Metastasis Rev 18:31-42
34. Vagenas K, Spyropoulos C, Gavala V et al. (2007) TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res 139:182-8
35. Valcourt U, Kowanetz M, Niimi H et al. (2005) TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithe-lial-mesenchymal cell transition. Mol Biol Cell 16:1987-2002
36. Van Kranen HJ, Westerman A, Berg RJ et al. (2005) Dose-dependent effects of UVB-induced skin carcinogenesis in hairless p53 knockout mice. Mutat Res 571:81-90
37. Xie L, Law BK, Chytil AM et al. (2004) Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. Neoplasia (New York, NY) 6:603-10
38. Xing J, Ginty DD, Greenberg ME (1996) Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science (New York, NY) 273:959-63
39. Yue J, Mulder KM (2001) Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol Ther 91:1-34
40. Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24:5764-74